1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Jinghui Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy. Tafolecimab, Sintilimab, Nab paclitaxel - Lung Cancer | Phase 2 | Recruiting | Jinghui Wang | 30 | 2024-05-17 | 2024-05-20 |
Lung Neoplasms (1)
Docetaxel (1) · Gemcitabine (1) · Taxes (1) · sintilimab (1)
China (1)